Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Mar. 31, 2020 $ 9,368 $ 121,426,563 $ (112,026,381) $ (132,124) $ 9,277,426
Beginning balance, shares at Mar. 31, 2020 9,366,873        
Issuances of common stock for cash under at the market program $ 2,686 7,258,183 7,260,869
Issuances of common stock for cash under at the market program, shares 2,685,600        
Stock-based compensation expense 84,207 84,207
Net loss (1,410,283) (863) (1,411,146)
Ending balance, value at Jun. 30, 2020 $ 12,072 128,744,684 (113,436,664) (132,987) 15,187,105
Ending balance, shares at Jun. 30, 2020 12,070,393        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise $ 18 (24,269) (24,251)
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 17,920        
Beginning balance, value at Mar. 31, 2021 $ 12,152 129,331,542 (119,913,090) (136,914) 9,293,690
Beginning balance, shares at Mar. 31, 2021 12,150,597        
Issuances of common stock for cash under at the market program $ 626 4,947,159 4,947,785
Issuances of common stock for cash under at the market program, shares 626,000        
Issuances of common stock for cash in registered direct financing $ 1,381 11,657,663 11,659,044
Issuances of common stock for cash in registered direct financing, shares 1,380,555        
Issuances of common stock for cash under warrant exercises $ 531 820,407 820,938
Issuances of common stock for cash under warrant exercises, shares 531,167        
Issuances of common stock for cash under stock option exercises $ 11 28,314 28,325
Issuances of common stock for cash under stock option exercises, shares 11,562        
Issuances of common stock under cashless warrant exercises $ 676 (676)
Issuances of common stock under cashless warrant exercises, shares 675,554        
Issuance of common shares upon vesting of restricted stock units $ 11 (35,797) (35,786)
Issuance of common shares upon vesting of restricted stock units, shares 10,932        
Stock-based compensation expense 120,154 120,154
Net loss (2,097,303) (1,135) (2,098,438)
Ending balance, value at Jun. 30, 2021 $ 15,388 $ 146,868,766 $ (122,010,393) $ (138,049) $ 24,735,712
Ending balance, shares at Jun. 30, 2021 15,386,367